193 related articles for article (PubMed ID: 28011125)
21. Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling.
Shono Y; Jantratid E; Janssen N; Kesisoglou F; Mao Y; Vertzoni M; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2009 Sep; 73(1):107-14. PubMed ID: 19465123
[TBL] [Abstract][Full Text] [Related]
22. An in silico approach to determine challenges in the bioavailability of ciprofloxacin, a poorly soluble weak base with borderline solubility and permeability characteristics.
Hansmann S; Miyaji Y; Dressman J
Eur J Pharm Biopharm; 2018 Jan; 122():186-196. PubMed ID: 29111469
[TBL] [Abstract][Full Text] [Related]
23. An in vitro methodology for forecasting luminal concentrations and precipitation of highly permeable lipophilic weak bases in the fasted upper small intestine.
Psachoulias D; Vertzoni M; Butler J; Busby D; Symillides M; Dressman J; Reppas C
Pharm Res; 2012 Dec; 29(12):3486-98. PubMed ID: 22890986
[TBL] [Abstract][Full Text] [Related]
24. In vivo analysis of supersaturation/precipitation/absorption behavior after oral administration of pioglitazone hydrochloride salt; determinant site of oral absorption.
Tanaka Y; Sugihara M; Kawakami A; Imai S; Itou T; Murase H; Saiki K; Kasaoka S; Yoshikawa H
Eur J Pharm Sci; 2017 Aug; 106():431-438. PubMed ID: 28603033
[TBL] [Abstract][Full Text] [Related]
25. Revisiting Supersaturation of a Biopharmaceutical Classification System IIB Drug: Evaluation via a Multi-Cup Dissolution Approach and Molecular Dynamic Simulation.
Gan Y; Xu Y; Zhang X; Hu H; Xiao W; Yu Z; Sun T; Zhang J; Wen C; Zheng S
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836805
[TBL] [Abstract][Full Text] [Related]
26. In Vitro-In Vivo Correlation in Cocrystal Dissolution: Consideration of Drug Release Profiles Based on Coformer Dissolution and Absorption Behavior.
Kataoka M; Minami K; Takagi T; Amidon GE; Yamashita S
Mol Pharm; 2021 Nov; 18(11):4122-4130. PubMed ID: 34618448
[TBL] [Abstract][Full Text] [Related]
27. In Vitro, in Silico, and in Vivo Assessments of Intestinal Precipitation and Its Impact on Bioavailability of a BCS Class 2 Basic Compound.
Kou D; Zhang C; Yiu H; Ng T; Lubach JW; Janson M; Mao C; Durk M; Chinn L; Winter H; Wigman L; Yehl P
Mol Pharm; 2018 Apr; 15(4):1607-1617. PubMed ID: 29522347
[TBL] [Abstract][Full Text] [Related]
28. Advances and challenges in PBPK modeling--Analysis of factors contributing to the oral absorption of atazanavir, a poorly soluble weak base.
Berlin M; Ruff A; Kesisoglou F; Xu W; Wang MH; Dressman JB
Eur J Pharm Biopharm; 2015 Jun; 93():267-80. PubMed ID: 25872159
[TBL] [Abstract][Full Text] [Related]
29. Integrating Forward and Reverse Translation in PBPK Modeling to Predict Food Effect on Oral Absorption of Weakly Basic Drugs.
Franco YL; Da Silva L; Charbe N; Kinvig H; Kim S; Cristofoletti R
Pharm Res; 2023 Feb; 40(2):405-418. PubMed ID: 36788156
[TBL] [Abstract][Full Text] [Related]
30. Development of a Unified Dissolution and Precipitation Model and Its Use for the Prediction of Oral Drug Absorption.
Jakubiak P; Wagner B; Grimm HP; Petrig-Schaffland J; Schuler F; Alvarez-Sánchez R
Mol Pharm; 2016 Feb; 13(2):586-98. PubMed ID: 26674605
[TBL] [Abstract][Full Text] [Related]
31. Automated small-scale in vitro transfer model as screening tool for the prediction of in vivo-dissolution and precipitation of poorly solubles.
Jede C; Wagner C; Kubas H; Weber C; Weigandt M; Koziolek M; Weitschies W
Int J Pharm; 2019 Feb; 556():150-158. PubMed ID: 30553006
[TBL] [Abstract][Full Text] [Related]
32. In vitro methods to assess drug precipitation in the fasted small intestine - a PEARRL review.
O'Dwyer PJ; Litou C; Box KJ; Dressman JB; Kostewicz ES; Kuentz M; Reppas C
J Pharm Pharmacol; 2019 Apr; 71(4):536-556. PubMed ID: 29956338
[TBL] [Abstract][Full Text] [Related]
33. A stereospecific high-performance liquid chromatographic assay for the determination of ketoconazole enantiomers in rat plasma.
Hamdy DA; Brocks DR
Biomed Chromatogr; 2008 May; 22(5):542-7. PubMed ID: 18205135
[TBL] [Abstract][Full Text] [Related]
34. The effect of increased lipoprotein levels on the pharmacokinetics of ketoconazole enantiomers in the rat.
Hamdy DA; Brocks DR
Xenobiotica; 2011 Feb; 41(2):137-43. PubMed ID: 21058917
[TBL] [Abstract][Full Text] [Related]
35. A pH-dilution method for estimation of biorelevant drug solubility along the gastrointestinal tract: application to physiologically based pharmacokinetic modeling.
Gao Y; Carr RA; Spence JK; Wang WW; Turner TM; Lipari JM; Miller JM
Mol Pharm; 2010 Oct; 7(5):1516-26. PubMed ID: 20715778
[TBL] [Abstract][Full Text] [Related]
36. The absorption kinetics of ketoconazole plays a major role in explaining the reported variability in the level of interaction with midazolam: Interplay between formulation and inhibition of gut wall and liver metabolism.
Liu B; Crewe HK; Ozdemir M; Rowland Yeo K; Tucker G; Rostami-Hodjegan A
Biopharm Drug Dispos; 2017 Apr; 38(3):260-270. PubMed ID: 28004396
[TBL] [Abstract][Full Text] [Related]
37. An in vitro-in silico-in vivo approach to predicting the oral pharmacokinetic profile of salts of weak acids: case example dantrolene.
Kambayashi A; Dressman JB
Eur J Pharm Biopharm; 2013 May; 84(1):200-7. PubMed ID: 23262163
[TBL] [Abstract][Full Text] [Related]
38. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.
Shono Y; Jantratid E; Kesisoglou F; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2010 Sep; 76(1):95-104. PubMed ID: 20576487
[TBL] [Abstract][Full Text] [Related]
39. Simulation of Intraluminal Performance of Lipophilic Weak Bases in Fasted Healthy Adults Using DDDPlus
Statelova M; Vertzoni M; Kourentas A
AAPS J; 2022 Aug; 24(5):89. PubMed ID: 35974242
[TBL] [Abstract][Full Text] [Related]
40. Evaluating the predictability of the in vitro transfer model and in vivo rat studies as a surrogate to investigate the supersaturation and precipitation behaviour of different Albendazole formulations for humans.
Ruff A; Holm R; Kostewicz ES
Eur J Pharm Sci; 2017 Jul; 105():108-118. PubMed ID: 28473227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
